Dr Thomas Hudzik is the Founder and Principal Executive of AlaBioPharma. He has worked in Industry for 30+ years as a pharmacologist, neuroscientist, toxicologist and program director from early research through to proof of concept in clinic. He and his teams have shepherded 4 small molecules and a cell therapy to clinical stage and prepared INDs, NDAs, eINDs, iINDS, 505bs and ANDAs. He has published more than 75 peer-reviewed scientific papers and book chapters. His globally recognized, deep expertise in assessment of the potential for abuse for new drugs, as well as in Central Nervous System Pharmacology and Toxicology allows him access to a global network of scientists. He has applied his expertise in support of NIH, the World Anti-Doping Agency, academicians, start-ups and big pharma for more than a decade.